A discovery by a team of B.C. researchers may lead to improved COVID-19 treatment options that are effective against several variants of the disease.
Researchers at the University of British Columbia say they’ve found a “weak spot” in COVID-19 variants, including in the latest Omicron subvariants. Their findings were published in Nature Communications on Thursday.
“This is a highly adaptable virus that has evolved to evade most existing antibody treatments, as well as much of the immunity conferred by vaccines and natural infection,” said Dr. Sriram Subramaniam, a professor at UBC’s faculty of medicine and the study’s senior author, in a news release.
“This study reveals a weak spot that is largely unchanged across variants and can be neutralized by an antibody fragment. It sets the stage for the design of pan-variant treatments that could potentially help a lot of vulnerable people.”
